GSVCX
Price
$13.58
Change
+$0.19 (+1.42%)
Updated
Apr 11 closing price
Net Assets
393.4M
VIVAX
Price
$63.21
Change
+$0.94 (+1.51%)
Updated
Apr 11 closing price
Net Assets
190.51B
Ad is loading...

GSVCX vs VIVAX

Header iconGSVCX vs VIVAX Comparison
Open Charts GSVCX vs VIVAXBanner chart's image
Goldman Sachs Large Cap Value C
Price$13.58
Change+$0.19 (+1.42%)
VolumeN/A
Net Assets393.4M
Vanguard Value Index I
Price$63.21
Change+$0.94 (+1.51%)
VolumeN/A
Net Assets190.51B
GSVCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVCX vs. VIVAX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVCX is a Buy and VIVAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. GSVCX (393M). VIVAX pays higher dividends than GSVCX: VIVAX (2.14) vs GSVCX (0.32). GSVCX was incepted earlier than VIVAX: GSVCX (25 years) vs VIVAX (32 years). GSVCX (2.00) is less costly to investors than VIVAX (0.17). GSVCX is a more actively managed with annual turnover of: 51.00 vs. VIVAX (10.00). GSVCX has a lower initial minimum investment than VIVAX: GSVCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 0.72 vs. GSVCX (-11.43). VIVAX return over 5 years is better than : 64.30 vs. GSVCX (15.81).
GSVCXVIVAXGSVCX / VIVAX
Total Expense Ratio1.750.171,029%
Annual Report Gross Expense Ratio2.000.171,176%
Fund Existence25 years32 years-
Gain YTD-8.036-5.712141%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets393M191B0%
Annual Yield % from dividends0.322.1415%
Returns for 1 year-11.430.72-1,594%
Returns for 3 years-11.488.14-141%
Returns for 5 years15.8164.3025%
Returns for 10 years-20.1588.68-23%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.440.02
+5.69%
Lyell Immunopharma
CPRX22.050.60
+2.80%
Catalyst Pharmaceuticals
INNV2.820.06
+2.17%
InnovAge Holding Corp
UHAL61.040.18
+0.30%
U-Haul Holding Company
NLSP1.35N/A
-0.01%
Nls Pharmaceutics Ltd